National Health Determination under paragraph 98C(1)(b) Amendment 2016 (No. 1) (PB 3 of 2016) (Cth)

PB 3 of 2016

National Health Determination under paragraph 98C(1)(b) Amendment 2016
(No. 1)

_____________________________________________________________________

I, JULIANNE QUAINE, First Assistant Secretary (Acting), Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this Instrument under paragraph 98C(1)(b) of the National Health Act 1953.

Dated 27 January 2016

JULIANNE QUAINE

First Assistant Secretary (Acting)

Pharmaceutical Benefits Division

Department of Health

1              Name of Instrument

(1)This Instrument is the National Health Determination under paragraph 98C(1)(b) Amendment 2016 (No. 1).

(2)This Instrument may also be cited as PB 3 of 2016.

2              Commencement  

This instrument commences on 1 February 2016.

3              Amendments to Determination under paragraph 98C(1)(b) of the National Health Act 1953 (PB 119 of 2008)

Schedule 1 amends the Determination under paragraph 98C(1)(b) of the National Health Act 1953 (PB 119 of 2008).

Schedule 1            Amendments

1. Schedule 3, after entry for Fentanyl in the form Lozenge 1600 micrograms (as citrate)

insert in the column headed “Form (strength, type, size, etc.)”:

Tablet (sublingual) 100 micrograms (as citrate)

Tablet (sublingual) 200 micrograms (as citrate)

Tablet (sublingual) 300 micrograms (as citrate)

Tablet (sublingual) 400 micrograms (as citrate)

Tablet (sublingual) 600 micrograms (as citrate)

Tablet (sublingual) 800 micrograms (as citrate)